All Press Releases
PILA PHARMA PARTICIPATED IN INVESTMENT PODCAST 10X
Malmö, 16 June 2025 PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition for treatment of obesity and diabetes, informs investors and others with interest in the space of the participation in a new podcast episode! CEO Gustav H. Gram participated in person with Joakim Båge from Swedish investment focused podcast, 10X,…
PILA PHARMA INVITES TO AFTER-WORK MINGLE IN STOCKHOLM
Malmö, 10 June 2025 PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition for treatment of obesity and diabetes, hereby invites investors and others with interest to join for an after-work event!PILA PHARMA will sponsor a few drinks per attendee.Wednesday 11 June, 18:00-20:00 CETGenerator Hostel Stockholm, Torsgatan 10, 111 23…
PILA PHARMA UPCOMING INVESTOR PRESENTATIONS IN STOCKHOLM
Malmö, 10 June 2025 PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition for treatment of obesity and diabetes, hereby invites investors and others with interest in the space to these coming events: ___________10X Podcast (Online Recording - Stockholm, Sweden)Wednesday 11 June from 11:00 CETCEO Gustav H. Gram will participate…